Skip to main content
. 2020 Nov 10;10:138. doi: 10.1186/s13550-020-00730-1

Fig. 5.

Fig. 5

ROC curve of the SUVmax for high-risk prostate cancers. 95% confidence interval [CI], 0.749–0.909; sensitivity: 90.4%; specificity: 65.3%